<- Go Home
Eon Labs, Inc.
Eon Labs, Inc., a generic pharmaceutical company, develops, manufactures, and distributes prescription pharmaceutical products in the United States. The company focuses on drugs in various solid oral dosage forms, utilizing both immediate and sustained release delivery, in tablet, multiple layer tablet, film-coated tablet, and capsule forms. It sells its products primarily to drug wholesalers, national drug chains, and mail order accounts, as well as Health Maintenance Organizations (HMOs). The company has a strategic relationship with Hexal Pharmaceuticals, Inc. to develop generic transdermal patch products that utilize transdermal patch delivery technology. Eon Labs, Inc. was formerly known as Eon Labs Manufacturing, Inc. The company was incorporated in 1992 and is based in Lake Success, New York. As of January 28, 2021, Eon Labs, Inc. operates as a subsidiary of Sandoz International GmbH.
Market Cap
$2.8B
Volume
899.4K
Cash and Equivalents
$63.3M
EBITDA
$195.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$238.4M
Profit Margin
55.74%
52 Week High
$31.15
52 Week Low
$21.05
Dividend
N/A
Price / Book Value
5.85
Price / Earnings
24.79
Price / Tangible Book Value
6.78
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$184.2M
Return on Equity
27.25%
Return on Assets
22.13
Cash and Short Term Investments
$229.0M
Debt
N/A
Equity
$470.5M
Revenue
$427.8M
Unlevered FCF
$51.0M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium